V. Bryan Lawlis - Director at Spyre Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
AGLE on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by V. Bryan Lawlis since 7/7/2023

Holdings reported by V. Bryan Lawlis for Spyre Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Director Stock Option (right to buy) 43,000 Jun 7, 2022 Direct Common Stock

Transactions reported by V. Bryan Lawlis for Spyre Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership